Phesgo 80 mg

PHESGO 80 MG is a subcutaneous solution containing pertuzumab, used in cancer treatment. This medication is designed for targeted therapy, often in combination with other treatments.

PHESGO 80 MG is primarily used in the treatment of certain types of cancer. It is often administered as part of a combination therapy regimen. The medication works by targeting specific proteins involved in cancer cell growth. PHESGO 80 MG is typically prescribed for patients with HER2-positive breast cancer, helping to slow or stop the progression of the disease.

Common effects of PHESGO 80 MG may include reactions at the injection site, such as redness, swelling, or pain. Some patients may experience fatigue, nausea, or diarrhea. These effects are generally mild and temporary, but severe reactions should be reported to a healthcare provider immediately.

PHESGO 80 MG should be handled with care and administered by a healthcare professional. It is important to follow the prescribed dosage and schedule. Patients should inform their healthcare provider about any allergies or medical conditions before starting treatment. Proper storage and handling instructions should be followed to maintain the medication's effectiveness.

PHESGO 80 MG may interact with other medications, including those that affect the immune system. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and certain foods may also affect the medication's efficacy, so patients should follow their healthcare provider's advice regarding lifestyle adjustments.